KRRO: Korro Bio Inc

KRRO新闻

• 13:01 Thursday’s insider buys and sells: AdaptHealth leads activity
• 12:20 Cantor Fitzgerald上调Korro Bio目标价,对尿素循环障碍项目信心增强
• 12:18 Cantor Fitzgerald raises Korro Bio stock price target on UCD confidence
• 09:18 Raymond James因高氨血症转型上调Korro Bio股票评级
• 09:15 Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot
• 00:44 Baskett Forest买入Korro Bio (KRRO)股票,价值230万美元
• 00:43 Baskett Forest buys Korro Bio (KRRO) shares worth $2.3 million
• 00:36 Korro Bio投资者斥资230万美元增持KRRO股票
• 00:36 Nea 17以230万美元购入Korro Bio (KRRO)股票
• 00:34 Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million
• 00:34 Korro Bio investor buys $2.3 million in KRRO stock
• 23:20 Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates
• 10:09 United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains?
• 11:39 Korro Bio通过私募股权融资筹集8500万美元
• 11:37 Korro股价因8500万美元私募融资飙升17%
• 11:37 Korro Bio raises $85 million in private equity financing
• 11:36 Korro stock surges 17% on $85M private placement financing
• 17:15 Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
• 22:13 Clear Street因高氨血症项目潜力上调Korro Bio股票评级
• 22:11 Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential
• 12:35 Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?